| pubmed-article:1083513 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1083513 | lifeskim:mentions | umls-concept:C0042721 | lld:lifeskim |
| pubmed-article:1083513 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
| pubmed-article:1083513 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1083513 | pubmed:dateCreated | 1976-7-6 | lld:pubmed |
| pubmed-article:1083513 | pubmed:abstractText | Peripheral blood lymphocytes were investigated in 20 patients with acute viral hepatitis. For assessment of B lymphocytes the rosette test was carried out using sheep erythrocytes coated with antibodies and murine complement. T lymphocytes were recognized by their ability of binding uncoated sheep erythrocytes. In 16 cases the results of EAC test in patients with viral hepatitis resembled those in healthy donors. In 3 cases a significant decrease was observed and in one case a significant rise was found in the number of cells forming EAC rosettes. The T lymphocyte count was within normal range in 19 investigated cases. The results suggest that impaired T lymphocyte reactivity to PHA in acute viral hepatitis is due to a disturbed function of T lymphocytes and not to a decrease in their number. In cases associated with significant hepatocellular damage a reduction in the number of circulating B lymphocytes was observed. | lld:pubmed |
| pubmed-article:1083513 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1083513 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1083513 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1083513 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1083513 | pubmed:issn | 0301-0236 | lld:pubmed |
| pubmed-article:1083513 | pubmed:author | pubmed-author:NowakJJ | lld:pubmed |
| pubmed-article:1083513 | pubmed:author | pubmed-author:Szkaradkiewic... | lld:pubmed |
| pubmed-article:1083513 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1083513 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:1083513 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1083513 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1083513 | pubmed:pagination | 149-54 | lld:pubmed |
| pubmed-article:1083513 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:meshHeading | pubmed-meshheading:1083513-... | lld:pubmed |
| pubmed-article:1083513 | pubmed:articleTitle | B and T lymphocytes in viral hepatitis. | lld:pubmed |
| pubmed-article:1083513 | pubmed:publicationType | Journal Article | lld:pubmed |
